Integrated clinicopathologic and molecular risk stratification for disease recurrence in muscle-invasive bladder cancer. This is an ASCO Meeting Abstract from the 2021 Genitourinary Cancers Symposium.
Research at Stanford Medicine suggests that a urine test may. be able to determine which patients will benefit from additional therapy.
Cystoscopic evaluation identified a large bladder tumor on the right lateral/posterior wall. August 2013: Transurethral resection of bladder tumor identified high grade papillary urothelial carcinoma ...
All patients with a Current Procedural Terminology code for transurethral resection of bladder tumor (TURBT; n = 76,060) were selected from the Department of Veterans Affairs (VA) database. A sample ...
WILMINGTON, Del.--(BUSINESS WIRE)--Results from a post-hoc exploratory subgroup analysis from the NIAGARA Phase III trial showed AstraZeneca’s IMFINZI ® (durvalumab), administered perioperatively in ...
Editor's Note: This is an excerpt from WBUR's weekly health newsletter, CommonHealth. If you like what you read and want it in your inbox, sign up here. Bladder cancer hits men especially hard. The ...
Bladder cancer (BCa) is the most prevalent urinary tract malignancy and is costly to cure. Recently, AI algorithms have been used in BCa diagnosis and outcome prediction. These tasks include automated ...
The term neurogenic bladder is defined as bladder dysfunction resulting from damage to the nerves that control the bladder in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results